These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16128956)

  • 21. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
    Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
    Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy.
    Leal YA; Gómez A; Madrazo-de la Garza A; Ramos I; Muñoz O; Torres J
    Rev Invest Clin; 2008; 60(6):470-7. PubMed ID: 19378833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
    Gisbert JP; Olivares D; Jimenez I; Pajares JM
    Dig Liver Dis; 2006 Apr; 38(4):254-9. PubMed ID: 16309984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Helicobacter pylori infection in children].
    Raymond J; Kalach N
    Rev Prat; 2006 Jan; 56(1):5-12. PubMed ID: 16548242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy.
    Czesnikiewicz-Guzik M; Loster B; Bielanski W; Guzik TJ; Konturek PC; Zapala J; Konturek SJ
    J Clin Gastroenterol; 2007 Feb; 41(2):145-51. PubMed ID: 17245212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
    Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T
    Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Helicobacter pylori and the mouth cavity--overview and perspectives].
    Schein W; Meryn S
    Wien Klin Wochenschr; 1994; 106(17):547-9. PubMed ID: 7975669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori in the oral cavity and its implications for gastric infection, periodontal health, immunology and dyspepsia.
    Czesnikiewicz-Guzik M; Bielanski W; Guzik TJ; Loster B; Konturek SJ
    J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():77-89. PubMed ID: 16340041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between Helicobacter pylori in oral cavity and the Hp infection in stomach].
    Hou HL; Meng HX; Hu WJ; Wang JW
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Sep; 38(5):327-9. PubMed ID: 14680575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
    Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
    Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.